Britain Approves AstraZeneca Vaccine, Offering Hope Amid Surge in COVID-19 Infections - Voice of America

by voanews 12/30/2020

Britain became the first country to approve the coronavirus vaccine developed jointly by Oxford University and AstraZeneca Wednesday. Scientists say the vaccine could be a game changer in the global fight against the pandemic.    Regulators say the vaccine has shown around 70% effectiveness against COVID-19, a relatively high figure compared to vaccines for many other diseases.    “This vaccine, COVID-19 vaccine AstraZeneca, has been approved for use in people aged 18 years and older, with two standard doses, four to 12 weeks apart,” said Dr.


While we at home isolate and reduce our societal interaction, military members continue to interact with hundreds if not thousands of other military personnel every day. How has Covid-19 impacted the United States’ armed forces, and will vaccines enable them to return to business as usual?


With the first US case of a new more contagious variant of coronavirus first reported in the UK, there are likely more cases across the country than currently being reported, according to Dr. Tara Kirk Sell of Johns Hopkins University. “Definitely,” said Dr. Sell Monday morning in an interview with The National Desk anchor Jan Jeffcoat. “I think it’s pretty safe to assume that this variant is in multiple regions of the country.